http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004072092-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f03477a8b3cba17871dac32f24660749
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d9af9d7aa2568650642b3356b98363d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3e3e5e044cc8d69202fc523a93bea66
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00
filingDate 2004-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6edc42fe69d38a4ab73f689e93cd2f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c484d22e516ea478546f7c1ff34b8138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27c42d0168ddb7c357a09dbef5892318
publicationDate 2004-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004072092-A1
titleOfInvention Medicament for inhibiting tumour growth
abstract The invention relates to novel derivatives of betulinic acid with increased activity for the treatment of carcinomas and HIV diseases, to a method for producing novel betulinic acid derivatives of this type and to their use as medicaments.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009530405-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501380-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009090063-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2561604-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9067966-B2
priorityDate 2003-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9629068-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002052352-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5962527-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129679482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15858984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68440821
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22857346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229755826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227690221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248564970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228984134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68778704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443376
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246998501
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67049801
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246750582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87249834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409

Total number of triples: 60.